Windtree Therapeutics Enters Material Definitive Agreement

Ticker: WINTW · Form: 8-K · Filed: Apr 10, 2025 · CIK: 946486

Windtree Therapeutics Inc /De/ 8-K Filing Summary
FieldDetail
CompanyWindtree Therapeutics Inc /De/ (WINTW)
Form Type8-K
Filed DateApr 10, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, financial-obligation

TL;DR

Windtree Therapeutics just signed a big deal, creating a new financial obligation.

AI Summary

On April 4, 2025, Windtree Therapeutics, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as Discovery Laboratories Inc. and Ansan Pharmaceuticals Inc., is based in Warrington, PA.

Why It Matters

This filing indicates a significant new financial commitment or obligation for Windtree Therapeutics, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into new financial obligations can introduce financial risk if not managed effectively.

Key Players & Entities

  • Windtree Therapeutics, Inc. (company) — Registrant
  • April 4, 2025 (date) — Date of earliest event reported
  • Discovery Laboratories Inc. /DE/ (company) — Former company name
  • Ansan Pharmaceuticals Inc. (company) — Former company name
  • Warrington, PA (location) — Business and mail address

FAQ

What is the nature of the material definitive agreement entered into by Windtree Therapeutics?

The filing states that Windtree Therapeutics, Inc. entered into a material definitive agreement on April 4, 2025, which also constitutes the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on April 4, 2025.

What are the former names of Windtree Therapeutics, Inc.?

Windtree Therapeutics, Inc. was formerly known as Discovery Laboratories Inc. /DE/ and Ansan Pharmaceuticals Inc.

Where is Windtree Therapeutics, Inc. located?

Windtree Therapeutics, Inc. is located in Warrington, PA, with its business and mail address at 2600 Kelly Road, Suite 100, Warrington, PA 18976.

What is the SIC code for Windtree Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code for Windtree Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.